Table 3. Correlation between the primary tumors and the peritoneal effusions: Morphological and ICC profiles.
| Primitive Cancers | SM/PM (105/68) | Antibody Tested On Cytological And Cell Block Samples° | |
|---|---|---|---|
| Unknown (27 cases) | 20/7 | Positive*: 1 Vimentin;7 Calretinin, 1 TTF-1; 6 CEA; 20 CAM 5.2M; 7 BER-EP4; 2 CK7, 3 CK20, 1 WT1, 4 CD68 | |
| Breast Ca (2 cases) | 0/2 | Positive: CK7;GCDFP15;ER;PR;E-Cadherin Negative: TTF-1, Calretinin, CK5/6. | |
| Lung Ca (7 cases) | 2/5 | Positive:TTF-1;CAM5.2;CK7; p63. Negative: S100, Calretinin, CK5/6 | |
| Gynecological Ca (83 cases) | |||
| • Ovarian Ca (71 cases) | 36/35 | Positive: CA125, WT1,CAM 5.2, CK7, ER, PR, CEA. Negative: S100,CK5/6, Calretinin, CK20, CDX2 | |
| • Endometrial Ca (11 cases) | 11/0 | ||
| • Tubaric-ovarian Ca (1 cases) | 1/0 | ||
| Mesothelioma (6 cases) | 3/3 | Positive: CAM 5.2, Calretinin, HBME-1, Podoplanin. Negative: TTF-1 | |
| Gastro-Intestinal Ca (39 cases) | |||
| • Stomach-Intestinal Ca (27 cases) | 24/3 | Positive: CAM 5.2;CK20; CDX2. Negative: TTF-1, Calretinin, CK5/6. | |
| • Biliary Ca (6 cases) | 3/3 | ||
| • Pancreatic Ca (6 cases) | 3/3 | ||
| • Liver Ca (0 cases) | 0/0 | ||
| Lymphoma (1 case) | 1/0 | Positive: LCA, CD20, CD79A, CD30, CD15. Negative: TTF-1,CAM 5.2;CK20; CDX2, CK5/6, Calretinin. | |
| Renal-Urogenital Ca (4 cases) | 1/3 | Positive: EMA;CAM 5.2;Vimentin, CD10. Negative: Thyroglobulin; TTF-1. | |
| Melanoma (4 cases) | 0/4 | ||
Ca: Carcinoma;
* we reported the figures for positive results so that the remaining figures resulted as corresponding negative value;
° ICC was performed on both LBC stored slide and Cell block obtained from LBC stored material without any significant difference in the expression.